Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 719,887 | 731,967 | 644,395 | 498,987 | 437,768 |
| Cost of Goods | 363,830 | 358,112 | 293,274 | 250,127 | 238,029 |
| Gross Profit | 356,057 | 373,855 | 351,121 | 248,860 | 199,739 |
| Operating Expenses | 216,484 | 168,548 | 154,408 | 141,490 | 129,881 |
| Operating Income | 140,403 | 205,419 | 196,987 | 107,497 | 69,887 |
| Interest Expense | 25,481 | 30,343 | 27,158 | 1,846 | 885 |
| Other Income | 8,702 | 14,115 | -451 | 9,212 | 14,929 |
| Pre-tax Income | 123,624 | 189,191 | 169,378 | 114,863 | 83,931 |
| Income Tax | 25,530 | 29,672 | 31,833 | 23,477 | 20,630 |
| Net Income Continuous | 98,094 | 159,519 | 137,545 | 91,386 | 63,301 |
| Minority Interests | N/A | N/A | N/A | N/A | 1,185 |
| Net Income | $98,094 | $159,519 | $137,545 | $91,386 | $62,116 |
| EPS Basic Total Ops | 2.10 | 3.29 | 2.85 | 1.88 | 1.30 |
| EPS Basic Continuous Ops | 2.10 | 3.29 | 2.85 | 1.88 | 1.32 |
| EPS Diluted Total Ops | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 |
| EPS Diluted Continuous Ops | 2.03 | 3.06 | 2.60 | 1.74 | 1.27 |
| EPS Diluted Before Non-Recurring Items | 2.81 | 3.49 | 3.02 | 1.70 | 1.37 |
| EBITDA(a) | $200,453 | $264,418 | $246,421 | $132,732 | $93,373 |